Status:

ENROLLING_BY_INVITATION

Optimizing Stroke Prophylaxis of Acute Atrial Fibrillation With an Electronic Clinical Decision Support Tool

Lead Sponsor:

Oregon Health and Science University

Conditions:

Atrial Fibrillation

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Atrial fibrillation (AF) is the most common arrhythmia in the world, with significant morbidity and mortality. With appropriate oral anticoagulation, the risk of stroke due to atrial fibrillation decr...

Detailed Description

OBJECTIVES: AIM 1: Compare the magnitude of change of appropriate OAC prescribing over time at each ED with EHR-Based CDS tool implementation. H1a. A CDS tool will increase the prescribing of OACs a...

Eligibility Criteria

Inclusion

  • Inclusion Criteria (Patients):
  • A diagnosis of atrial fibrillation or paroxysmal atrial fibrillation (ICD-10 I48.0, I48.1, I48.9) during an ED visit with start dates between 1/11/2022 and 12/31/2025 within the patient's age \>18 years.
  • Exclusion Criteria (Patients):
  • Valvular disease, pregnancy, large esophageal varices, thrombocytopenia, severe or uncontrolled bleeding, severe liver or kidney disease, major surgery within 72 hours; OR
  • Recent brain, eye or spinal cord injury or surgery; OR
  • ED stroke, death or hospitalization at index visit; OR
  • Patient transferred from another hospital (to ensure availability of index ED visit data); OR
  • Left against medical advice; OR
  • Evidence of non-OAC naïve patient:
  • OAC prescribed in the prior 3mo to index ED visit; OR
  • Being managed by an anticoagulation clinic (ACC);
  • Inclusion/Exclusion Criteria (Clinicians): All ED clinicians (board certified or eligible) interfacing with patients.

Exclusion

    Key Trial Info

    Start Date :

    January 11 2022

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    May 1 2026

    Estimated Enrollment :

    36 Patients enrolled

    Trial Details

    Trial ID

    NCT05341986

    Start Date

    January 11 2022

    End Date

    May 1 2026

    Last Update

    March 20 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Oregon Health & Science University (OHSU)

    Portland, Oregon, United States, 97239